Human Reproduction Update, Vol.8, No.5 pp.449-462, 2002
© European Society of Human Reproduction and Embryology 2002; all rights reserved
Ovulation induction in perspective
1 Lis Maternity Hospital, Tel Aviv (Sourasky) Medical Centre, Tel Aviv, Israel (affiliated to Sackler School of Medicine, Tel Aviv University) and 2 Clalit Medical Services, Central Area, Rishon LeZion, Israel
To whom correspondence should be addressed at: Roy Homburg, Lis Maternity Hospital, Tel Aviv (Sourasky) Medical Centre, 6, Weizmann Street, Tel Aviv 64239, Israel. E-mail: homburg{at}netvision.net.il
Abstract
It has been suggested recently that, in some quarters, IVF be offered as first-line therapy to all infertile couples, regardless of the type of infertility. Hence, the time was thought right to scrutinise the results and complications of ovulation induction for anovulatory infertile couples. In addition to examining the outcome of conventional treatment with gonadotrophins and clomiphene citrate, special attention has been paid to the suggested improvement of results by taking into account the influence of obesity and the use of a low-dose gonadotrophin protocol. The possible contribution of more recent additions to the armamentarium such as insulin sensitizers and aromatase inhibitors, although still at an infant stage, are promising. Attention has been given to the prevention and treatment of ovarian hyperstimulation syndrome. The use of intra-uterine insemination (IUI) as an adjuvant to induction of ovulation and controlled ovarian hyperstimulation (COH) is examined. The very firm conclusion has been reached that, taking into account efficiency, complication rate and cost of treatment, at this stage, women with hypogonadotrophic hypogonadism or polycystic ovary syndrome should be offered accepted methods of ovulation induction and that couples with ‘unexplained’ or ‘multifactorial subfertility’ should still be exposed to COH with IUI and only after the failure of these therapies, be offered IVF.
Key words: anovulation / gonadotrophins / infertility / ovarian hyperstimulation syndrome / ovulation induction
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. Ombelet, G. Martens, P. De Sutter, J. Gerris, E. Bosmans, G. Ruyssinck, P. Defoort, G. Molenberghs, and W. Gyselaers Perinatal outcome of 12 021 singleton and 3108 twin births after non-IVF-assisted reproduction: a cohort study Hum. Reprod., April 1, 2006; 21(4): 1025 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. E. Messinis Ovulation induction: a mini review Hum. Reprod., October 1, 2005; 20(10): 2688 - 2697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Palomba, A. Falbo, F. Orio Jr, F. Manguso, T. Russo, A. Tolino, C. Annamaria, B. Dale, and F. Zullo A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination Hum. Reprod., October 1, 2005; 20(10): 2879 - 2886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Homburg Clomiphene citrate--end of an era? a mini-review Hum. Reprod., August 1, 2005; 20(8): 2043 - 2051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Ombelet, P. De Sutter, J. Van der Elst, and G. Martens Multiple gestation and infertility treatment: registration, reflection and reaction--the Belgian project Hum. Reprod. Update, January 1, 2005; 11(1): 3 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E.J.P. van Santbrink and B.C.J.M. Fauser Is there a future for ovulation induction in the current era of assisted reproduction? Hum. Reprod., December 1, 2003; 18(12): 2499 - 2502. [Abstract] [Full Text] [PDF]
|
|